(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-16 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 645390
| Date | Daily Closing Price | Open | High | Low | Volume |
| 16 Mon Sep 2024 | 86.30 | 89.11 | 89.11 | 85.82 | 0.831 times |
| 13 Fri Sep 2024 | 88.90 | 85.09 | 89.05 | 84.38 | 0.957 times |
| 12 Thu Sep 2024 | 84.10 | 86.58 | 86.65 | 83.91 | 0.728 times |
| 11 Wed Sep 2024 | 86.56 | 85.41 | 86.92 | 84.75 | 0.85 times |
| 10 Tue Sep 2024 | 85.99 | 86.92 | 87.05 | 84.27 | 1.077 times |
| 09 Mon Sep 2024 | 86.55 | 86.30 | 86.92 | 84.52 | 1.429 times |
| 06 Fri Sep 2024 | 86.43 | 91.45 | 91.76 | 84.51 | 2.391 times |
| 05 Thu Sep 2024 | 91.41 | 92.75 | 92.75 | 90.43 | 0.9 times |
| 04 Wed Sep 2024 | 92.61 | 91.95 | 92.80 | 91.00 | 0.551 times |
| 03 Tue Sep 2024 | 92.53 | 94.80 | 96.50 | 91.76 | 0.641 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 87.4, but if it comes above 87.4, then a intra day buy could be more profitable.
If you take a sell trade below 87.4, then use 87.4 as stoploss and 83 as target. However if you take a buy trade in stock , then use 87.4 as stoploss and 91.15 as target.
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 83.91 |
| Upside Target | 89.05 |
| Upside Target | 95.67 |
| Upside Target | 96.50 |
| Upside Target | 100.67 |
| Upside Target | 106.56 |
| Upside Target | 108.40 |
| Upside Target | 111.02 |
| Upside Target | 111.42 |
| Upside Target | 121.90 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 85.04 |
| Downside Intraday Target | 83.79 |
| Upside Intraday Target | 88.33 |
| Upside Intraday Target | 90.37 |
| Upside Intraday Target | 87.08 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 16 Mon Sep 2024 | 86.30 | 89.11 | 89.11 | 85.82 | 0.165 times |
| 13 Fri Sep 2024 | 88.90 | 86.30 | 89.05 | 83.91 | 1.124 times |
| 06 Fri Sep 2024 | 86.43 | 94.80 | 96.50 | 84.51 | 9.422 times |
| 30 Fri Aug 2024 | 95.54 | 94.52 | 95.67 | 93.14 | 0.184 times |
| 30 Fri Aug 2024 | 95.54 | 94.55 | 95.67 | 92.23 | 0.961 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 16 Mon Sep 2024 | 86.30 | 94.80 | 96.50 | 83.91 | 0.414 times |
| 30 Fri Aug 2024 | 95.54 | 106.51 | 108.40 | 89.35 | 1.157 times |
| 31 Wed Jul 2024 | 108.30 | 107.68 | 121.90 | 106.56 | 1.132 times |
| 28 Fri Jun 2024 | 107.78 | 106.43 | 111.42 | 100.67 | 0.902 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 87.6 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 87.6 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.